Evidence map›Paper›PMID 36865547›Full record

ReviewFrontiers in immunology2023

Exosome-derived CIRP: An amplifier of inflammatory diseases.

Jingrun Han, Yibo Zhang, Peng Ge, Tikam Chand Dakal, Haiyun Wen, Shuangfeng Tang, Yalan Luo, Qi Yang, Bianca Hua, Guixin Zhang and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Recent advances in biomarkers for cardiac fibrosis.Frontiers in cardiovascular medicine · 2026
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Anti-DAMP therapies for acute inflammation.Frontiers in immunology · 2025
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Jingrun HanDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yibo ZhangDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Peng GeDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Tikam Chand DakalGenome and Computational Biology Lab, Mohanlal Sukhadia University, Udaipur, Rajasthan, India.
Haiyun WenDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Shuangfeng TangDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Yalan LuoDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Qi YangDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Bianca HuaDepartment of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Biomedical Research Center, Comprehensive Cancer Center, Monrovia, CA, United States.
Guixin ZhangDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Hailong ChenDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Caiming XuDepartment of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
First Affiliated Hospital of Dalian Medical University · CNDalian Medical University · CNBeckman Research InstituteMohanlal Sukhadia University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold-inducible RNA-binding protein (CIRP) is an intracellular stress-response protein and a type of damage-associated molecular pattern (DAMP) that responds to various stress stimulus by altering its expression and mRNA stability. Upon exposure to ultraviolet (UV) light or low temperature, CIRP get translocated from the nucleus to the cytoplasm through methylation modification and stored in stress granules (SG). During exosome biogenesis, which involves formation of endosomes from the cell membrane through endocytosis, CIRP also gets packaged within the endosomes along with DNA, and RNA and other proteins. Subsequently, intraluminal vesicles (ILVs) are formed following the inward budding of the endosomal membrane, turning the endosomes into multi-vesicle bodies (MVBs). Finally, the MVBs fuse with the cell membrane to form exosomes. As a result, CIRP can also be secreted out of cells through the lysosomal pathway as Extracellular CIRP (eCIRP). Extracellular CIRP (eCIRP) is implicated in various conditions, including sepsis, ischemia-reperfusion damage, lung injury, and neuroinflammation, through the release of exosomes. In addition, CIRP interacts with TLR4, TREM-1, and IL-6R, and therefore are involved in triggering immune and inflammatory responses. Accordingly, eCIRP has been studied as potential novel targets for disease therapy. C23 and M3, polypeptides that oppose eCIRP binding to its receptors, are beneficial in numerous inflammatory illnesses. Some natural molecules such as Luteolin and Emodin can also antagonize CIRP, which play roles similar to C23 in inflammatory responses and inhibit macrophage-mediated inflammation. This review aims to provide a better understanding on CIRP translocation and secretion from the nucleus to the extracellular space and the mechanisms and inhibitory roles of eCIRP in diverse inflammatory illnesses.

Indexed as

ExosomesCell MembraneEndosomesExtracellular SpaceMultivesicular Bodiescold-inducible RNA-binding proteinexosomeimmune responseinflammationtargeted therapy

Identifiers

PMID36865547
PMCPMC9971932
OpenAlexW4320719504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.